Live Quote · NASDAQPCVXHealthcare· Biotechnology

Vaxcyte, Inc.

$55.39▼ 5.09%($-2.97)
MKT CAP $8.77BNEXT EARNINGS Feb 23, 2027
50%
Bullish
TickerSpark Score
43/100
▌ Weak
73
Valuation
20
Profitability
15
Growth
76
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a PCVX research report →

Analyst Price Target
$122.33+120.9% vs. today

Range $120 – $125

Analyst RatingBuy
11 Buy0 Hold0 Sell

Price Chart

+16.19% · this period
$73.82$58.44$43.06Nov 20May 26Nov 20
52-Week Range27% of range
Low
$42.40
Current
$55.39
High
$90.75